Response to everolimus is seen in TSC-associated SEGAs and angiomyolipomas independent of mutation type and site in TSC1 and TSC2.

Eur J Hum Genet · 2015 · PMC4795200 · PMID 25782670

Europe PMC DOI

hedged sentence

0.0662

closest p · 1.3× alpha

0.0662

boldest claim

The sentences

marginally significantP =0.0662so close (0.05 < p ≤ 0.1)

31 Thus, our findings here that TSC subjects with SEGA enrolled on EXIST-1 had a marginally significant increase in the proportion of TSC2 : TSC1 mutations, 87 vs 13% ( P =0.0662), fit these previous observations.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.